Researcher.Life Logo

Therapeutic Advances in Drug Safety : Impact Factor & More

eISSN: 2042-0994pISSN: 2042-0986
JournalOpen Access

Key Metrics

CiteScore
6.3
H-Index
42
Impact Factor
< 5
SJR
Q2Pharmacology (medical)
SNIP
1.67
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Therapeutic Advances in Drug Safety

Therapeutic Advances in Drug Safety Journal Specifications

Overview
Publisher SAGE PUBLICATIONS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2200
Publication Time9
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2010
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 9
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Therapeutic Advances in Drug Safety ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Therapeutic Advances in Drug Safety

Metabolic and nutritional stress-associated dilated cardiomyopathy in the setting of semaglutide use and long-term nicotine replacement therapy: a case report and literature review
  • 16 May 2026
  • Therapeutic Advances in Drug Safety
Medication-related nephrotic syndrome: a real-world study from 2004 to 2024 based on the Food and Drug Administration Adverse Event Reporting System
  • 15 May 2026
  • Therapeutic Advances in Drug Safety
Probable case of anaphylaxis due to hydrocortisone in a septic shock patient
  • 10 May 2026
  • Therapeutic Advances in Drug Safety
Increasing risk of hemorrhage following concurrent use of Salvia miltiorrhiza and oral anticoagulants: a retrospective self-controlled case series study
  • 10 May 2026
  • Therapeutic Advances in Drug Safety
Medication errors and medication error reporting practices in Ghana: a systematic review
  • 10 May 2026
  • Therapeutic Advances in Drug Safety
Adverse drug reactions associated with glycyrrhiza-containing Chinese patent medicines: a literature-based analysis of individual case reports and clinical trials.
  • 1 May 2026
  • Therapeutic advances in drug safety
Metabolic and nutritional stress-associated dilated cardiomyopathy in the setting of semaglutide use and long-term nicotine replacement therapy: a case report and literature review
  • 16 May 2026
  • Therapeutic Advances in Drug Safety
Medication-related nephrotic syndrome: a real-world study from 2004 to 2024 based on the Food and Drug Administration Adverse Event Reporting System
  • 15 May 2026
  • Therapeutic Advances in Drug Safety
Probable case of anaphylaxis due to hydrocortisone in a septic shock patient
  • 10 May 2026
  • Therapeutic Advances in Drug Safety
Increasing risk of hemorrhage following concurrent use of Salvia miltiorrhiza and oral anticoagulants: a retrospective self-controlled case series study
  • 10 May 2026
  • Therapeutic Advances in Drug Safety
Medication errors and medication error reporting practices in Ghana: a systematic review
  • 10 May 2026
  • Therapeutic Advances in Drug Safety
Adverse drug reactions associated with glycyrrhiza-containing Chinese patent medicines: a literature-based analysis of individual case reports and clinical trials.
  • 1 May 2026
  • Therapeutic advances in drug safety

FAQs on Therapeutic Advances in Drug Safety